PluriCells founder Ramiro Alberio highlights how academic partnerships drove cultivated meat commercialization

Suggested image filename: pluricells-ramiro-alberio-cultivated-meat-commercialization.webp

A question from industry rather than a formal commercialization strategy helped set Professor Ramiro Alberio on the path to creating PluriCells, a specialist stem cell platform serving the cultivated meat sector.

Alberio, Professor of Developmental Biology at the University of Nottingham, said the venture emerged after commercial organizations began asking whether the technology developed in his laboratory could be made available beyond academia.

• PluriCells was established after commercial partners sought access to pluripotent stem cell technologies developed in Professor Ramiro Alberio’s laboratory.
• The company supplied bespoke sheep, pig and cattle stem cell lines, alongside tailored growth media, to academic and commercial organizations in the UK, Europe and the USA.
• Revenue generated through licensing agreements was reinvested into research activities, supporting staff, technology development and wider scientific programs.

The result was PluriCells, which focuses on providing highly specialized pluripotent stem cell lines for cultivated meat research and development. The platform has since expanded its reach across the UK, Europe and the United States, supplying customized sheep, pig and cattle stem cell lines as well as tailored growth media to academic institutions and commercial companies.

Its work sits at a foundational stage of the cultivated meat value chain. As companies and researchers seek to advance cell-cultivated food production, demand has grown for the underlying cell technologies, expertise and biological tools needed to support development efforts.

Unlike many academic founders, Alberio did not begin by creating a spin-out company. Instead, the commercialization process initially centered on licensing agreements developed with support from the University of Nottingham’s technology transfer office.

Through this model, know-how and technology generated within the laboratory could be licensed directly to commercial partners. As interest in the technology increased, more organizations sought access to the cell lines and associated expertise developed by Alberio and his team.

The approach also created a mechanism for supporting further scientific work. Income generated through licensing activities could be reinvested into research programs, helping fund staff, develop new technologies and strengthen broader research capabilities.

Alongside the commercial growth of the platform, Alberio said the experience helped develop his understanding of entrepreneurship and innovation.

“I think being able to spot opportunities is important. That comes from listening to commercial partners, networking and understanding what the sector actually needs,” said Alberio.

Those interactions helped shape the evolution of the technology itself. Conversations with industry partners contributed not only to the development of stem cell lines but also to complementary products including specialist media and growth factors.

Alberio described the process as “developing projects together over time,” connecting academic research with industry requirements and emerging commercial opportunities.

While sections of the cultivated meat industry have faced financial and commercial challenges in recent years, Alberio noted that demand from academic researchers and international collaborators has continued to expand. His work now supports a broad range of activities across the ecosystem, including research programs, engineering projects, policy initiatives and infrastructure development.

Beyond commercial partnerships, Alberio has also contributed to wider discussions around regulation and future food systems. This includes involvement in the Food Standards Agency’s cultivated meat sandbox program and collaborations examining how cultivated meat production could interact with existing agricultural systems.

For Alberio, knowledge exchange remains a central part of the academic role. He said entrepreneurial activity had made his academic career “more interesting and more fun,” while also creating opportunities to demonstrate research impact, address challenges such as food security, expand professional networks and open new avenues for scientific investigation.

At the same time, he acknowledged that successful engagement beyond academia requires sustained effort, visibility and a willingness to participate in activities that extend beyond traditional research pathways.

His experience also illustrates an alternative model of academic entrepreneurship. Rather than beginning with the goal of building a high-growth company, commercialization developed gradually through relationships, collaboration and responsiveness to external demand.

The story formed part of the University of Nottingham’s Biosciences Innovation Accelerator (BIA), a program led by the School of Biosciences in partnership with the university’s IP & Commercialisation Office and the Faculty of Science Innovation Hub.

Led by Entrepreneur in Residence Dr Nell Masey O’Neill, the initiative aims to strengthen innovation, knowledge exchange and commercialization activity across the biosciences community. The program seeks to build a more connected and entrepreneurial research culture by increasing awareness of innovation pathways, supporting leadership development and helping researchers translate ideas into real-world impact.

Through engagement activities, coaching and collaborative projects, the BIA aims to strengthen links between researchers, industry and external partners while encouraging greater participation in innovation and knowledge exchange activities.

For Alberio, the experience demonstrated that commercialization does not always begin with a business plan or spin-out strategy. Sometimes, it starts with listening to industry needs and being prepared to explore opportunities as they emerge.